IE41055B1 - Pharmaceutical preparations having psycotropic activity and process for their manufacture - Google Patents

Pharmaceutical preparations having psycotropic activity and process for their manufacture

Info

Publication number
IE41055B1
IE41055B1 IE1068/75A IE106875A IE41055B1 IE 41055 B1 IE41055 B1 IE 41055B1 IE 1068/75 A IE1068/75 A IE 1068/75A IE 106875 A IE106875 A IE 106875A IE 41055 B1 IE41055 B1 IE 41055B1
Authority
IE
Ireland
Prior art keywords
pharmaceutical preparations
psycotropic
activity
manufacture
us4053588a
Prior art date
Application number
IE1068/75A
Other languages
English (en)
Other versions
IE41055L (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IE41055L publication Critical patent/IE41055L/xx
Publication of IE41055B1 publication Critical patent/IE41055B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IE1068/75A 1974-05-14 1975-05-13 Pharmaceutical preparations having psycotropic activity and process for their manufacture IE41055B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2423389A DE2423389A1 (de) 1974-05-14 1974-05-14 Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IE41055L IE41055L (en) 1975-11-14
IE41055B1 true IE41055B1 (en) 1979-10-10

Family

ID=5915522

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1068/75A IE41055B1 (en) 1974-05-14 1975-05-13 Pharmaceutical preparations having psycotropic activity and process for their manufacture

Country Status (11)

Country Link
US (1) US4053588A (enExample)
JP (1) JPS50157361A (enExample)
BE (1) BE829058A (enExample)
CA (1) CA1067410A (enExample)
DE (1) DE2423389A1 (enExample)
DK (1) DK207575A (enExample)
FR (1) FR2270867B1 (enExample)
GB (1) GB1503680A (enExample)
IE (1) IE41055B1 (enExample)
LU (1) LU72449A1 (enExample)
NL (1) NL7505479A (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492640A (en) * 1975-07-08 1977-11-23 Ucb Sa L-pyroglutamyl-l-prolinamide
US4868156A (en) * 1986-02-28 1989-09-19 Bio-Tech A/S Pharmaceutical preparation containing a dipeptide with cell growth regulating effect
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
US8673932B2 (en) 2003-08-12 2014-03-18 3M Innovative Properties Company Oxime substituted imidazo-containing compounds
AR045529A1 (es) 2003-08-27 2005-11-02 3M Innovative Properties Co Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US8598192B2 (en) 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
RU2409576C2 (ru) 2003-11-25 2011-01-20 3М Инновейтив Пропертиз Компани Системы, содержащие имидазольное кольцо с заместителями, и способы их получения
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
EP1730143A2 (en) 2004-03-24 2006-12-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
EP1831226B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Chiral tetracyclic compounds inducing interferon biosynthesis
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
EP1835915A4 (en) * 2004-12-30 2010-02-24 Coley Pharm Group Inc FORMULATIONS AND METHOD FOR MODIFYING THE IMMUNE RESPONSE
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
JP2008530113A (ja) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド オキシムおよびヒドロキシラミン置換イミダゾ［４，５−ｃ］環化合物および方法
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
EP1869043A2 (en) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
DE102014110783A1 (de) * 2014-07-30 2016-02-04 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE63496C (de) * B. A. DOBSON in Bolton, Grafsch. Lancaster, England, und E. APPENZELLER in Alost, Belgien Krempel mit Verringerung der Geschwindigkeit des Abnehmers beim Zerreifsen des Bandes
US3002978A (en) * 1958-05-06 1961-10-03 Bocher Gustave Marie Joseph Glyceryl pyrrolidone carboxylates
FR2207707A1 (en) * 1972-11-27 1974-06-21 Fabre Sa Pierre 2-Pyrrolidone-5-carboxylic acid esters and amides - with sedative and hypnotic activity

Also Published As

Publication number Publication date
DE2423389A1 (de) 1975-12-04
JPS50157361A (enExample) 1975-12-19
FR2270867B1 (enExample) 1978-08-04
LU72449A1 (enExample) 1977-02-09
DK207575A (da) 1975-11-15
GB1503680A (en) 1978-03-15
IE41055L (en) 1975-11-14
BE829058A (fr) 1975-11-14
CA1067410A (en) 1979-12-04
FR2270867A1 (enExample) 1975-12-12
NL7505479A (nl) 1975-11-18
US4053588A (en) 1977-10-11

Similar Documents

Publication Publication Date Title
IE41055B1 (en) Pharmaceutical preparations having psycotropic activity and process for their manufacture
ZA761118B (en) 1,4-dihydropyridine-carboxylic acid aralkyl esters,processes for their preparations and their use as medicaments
IE41064B1 (en) Peptides having lh-rh/fsh-rh activity and process for preparing them
IE42466L (en) Peptide derivatives of phosphonic and phosphinic acids.
GB1544647A (en) 2-piperidinoalkyl-1-benzofurans-1,4-benzodioxans and 1,4-benzoxathians process for their manufacture and pharmaceutical preparations containing them
AU496764B2 (en) new 2, 3-DIHYDRO-1-BENZOTHIEPIN-4-CARBOXAMIDES PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
GB1534351A (en) Indolylalkylpiperidines process for their manufacture and pharmaceutical preparations containing them
IE40267L (en) Alkanolamine derivatives
DE3164719D1 (en) Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation
AU8176175A (en) Pyrazolobenzazepines, process for their manufacture and pharmaceutical preparations containing them
IE44288L (en) Preparation of amino acid mixture.
ZA751560B (en) Pyrimidin-6-yl acethydroxamic acids, their process of preparation and their therapeutic application
AU6546780A (en) N-substituted amino acids, their production, and pharmaceutical preparations containing them
NL7613318A (nl) Werkwijze voor de bereiding van nieuwe n-gesubsti- tueerde pyrrolidoncarbonzuren, werkwijze voor de bereiding van therapeutische preparaten die deze nieuwe verbindingen bevatten, alsmede gevormd the- rapeutisch preparaat verkregen volgens deze werkwijze.
ZA79271B (en) 1-naphthyl-acetic acid derivatives,process for their preparation and their therapeutic applications
ZA777628B (en) New substituted 5-amino-2-pyridinecarboxylic acid compounds,process for their manufacture and pharmaceutical preparations containing them
AU513409B2 (en) Preparations of 3-N-pyrrolidino-4-phenoxy-5 sulfamylbenzoic acid and process for their manufacture
DE2861128D1 (en) Esters of n-pyrimidinyl-carboximidic acid, process for their preparation and medicines containing them.
IE39053B1 (en) Pharmaceutical compositions
ZA785599B (en) New piperazinopyrrolobenzodiazepines,process for their manufacture and pharmaceutical preparations containing them
NL7810163A (nl) Arylalkylalkaancarbonzuren, geneesmiddel met als werk- zaam bestanddeel alkaancarbonzuur en werkwijze voor de bereiding van de arylalkylalkaancarbonzuren.
AU483801B2 (en) New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids, process for their manufacture and pharmaceutical preparations containing them
AU495372B2 (en) Peptides having strong lh-rh/fsh-rh activity and process for their manufacture
AU491437B2 (en) Pyrimidin-6-yl acethydroxamic acids, their process of preparation and their therapeutic application
AU493473B2 (en) 3-amino-indazolecarboxylic acid derivatives, process for their preparation and their use as medicaments